CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 337 enrolled
Drug / intervention
Active Arm +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05015634
NCT05015634N/ACompleted

Remote Acute Assessment of Patients With High Cardiovascular Risk Post-Acute Coronary Syndrome

Imperial College London·interventional·Posted Aug 20, 2021·Updated Mar 17, 2026

In Brief

A clinical study evaluating Active Arm and Control Arm for Cardiovascular Diseases and Acute Coronary Syndrome. Completed, enrolled 337 participants across 1 site.

Detailed Summary

This is a non-CTIMP randomised controlled trial looking at the utilisation of telemedicine devices to provide remote, clinically necessary, diagnostic information, without the need for hospital attendance that patients will take home with them following admission to hospital with a heart attack.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 20, 2021
Enrollment StartJan 6, 2022
Primary CompletionFeb 28, 2025
Study CompletionMay 31, 2025
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 4.9 years ago

Interventions

Active Armother

Patient develops possible cardiac symptoms, takes an ECG, BP and oxygen saturation as per their training. Patient will receive a phone call by the trial cardiologist who will have access to a high-quality ECG trace, as well as blood pressure and oxygen saturations, and coupled with the clinical history, can decide on the most appropriate course of further management. With remote follow up over the phone at 3, 6 and 9 months.

Control Armother

Standard routine clinical care will be carried out, with remote follow up over the phone at 3, 6 and 9 months.